Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Boutou (Thessaloniki, Greece), K. Dipla (Thessaloniki, Greece), A. Zafeiridis (Thessaloniki, Greece), S. Papadopoulos (Thessaloniki, Greece), A. Markopoulou (Thessaloniki, Greece), I. Stanopoulos (Thessaloniki, Greece), G. Pitsiou (Thessaloniki, Greece). Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension. 3571

Member's Comments

No comment yet.

Related content which might interest you: Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Effects of mean pulmonary arterial pressure and supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemia Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017 Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 393-398 Year: 2008 Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Hemodynamic response to supplemental oxygen in chronic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Haemodynamics, exercise capacity and clinical events in pulmonary arterial hypertension Source: Eur Respir J 2013; 42: 414-424 Year: 2013 Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Epigenetic effects of exercise and respiratory training in patients with pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Effects of oxygen supplementation during pulmonary rehabilitation in COPD normoxemic patients Source: Annual Congress 2010 - Rehabilitation: more than just exercise Year: 2010 Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Short and long-term effects of pulmonary endarterectomy on ventilatory responses and exercise capacity of patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – The lungs and the heart during exercise Year: 2017 Haemodynamic effects of exercise therapy in stable, optimally treated pulmonary arterial hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013